New & Noteworthy

May 01, 2009
Pharmaceutical Executive
By Pharmaceutical Executive Editors
European docs have always been down on pharma—but now the US is catching on. Perhaps pharma has oversold the "service model."
May 01, 2009
Pharmaceutical Executive
Al Mann has sunk almost $1 billion of his own money into a new insulin delivery system. Will FDA be persuaded?
May 01, 2009
Pharmaceutical Executive
By Pharmaceutical Executive Editors
We leap tall buildings to bring you the definitive guide to the world's top pharmaceutical companies.
Jun 30, 0011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Harvey Berger, CEO at ARIAD Pharmaceuticals, discusses commercial strategy and his deal with Merck on a Phase 3 cancer drug.
native1_300x100
lorem ipsum